Switch to:
GuruFocus has detected 2 Warning Signs with Abbott Laboratories $ABT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Abbott Laboratories (NYSE:ABT)
Accounts Payable
{IF BankInsurance_zone 1}
$5,189 Mil (As of )Sep. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

Abbott Laboratoriess quarterly accounts payable declined from Mar. 2016 ($5,420 Mil) to Jun. 2016 ($5,420 Mil) and declined from Jun. 2016 ($5,416 Mil) to Sep. 2016 ($5,189 Mil)

Abbott Laboratoriess quarterly accounts payable increased from Dec. 2013 ($5,948 Mil) to Dec. 2014 ($5,948 Mil) but then declined from Dec. 2014 ($7,203 Mil) to Dec. 2015 ($5,683 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


Abbott Laboratories Annual Data

Accts Payable 5,0264,9337,9447,82410,86812,10510,8895,9487,2035,683
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 5,6495,5207,2035,9335,9945,9975,6835,4205,4165,189

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)